Ad
related to: cilostazol treatment for prostate cancer in men- XTANDI® FAQs For HCPs
Explore FAQs for Providers & Better
Prepare Your Patients.
- HCP Access & Support
Explore HCP Support Information and
Coverage Tools For Patients.
- Mechanism of Disease
Disease Information & Implications
Of Treatment with XTANDI®
- Mechanism of Action
Gain a Deeper Understanding of
How XTANDI® Is Thought to Work
- XTANDI® FAQs For HCPs
Search results
Results from the WOW.Com Content Network
Cilostazol, sold under the brand name Pletal among others, is a medication used to help the symptoms of intermittent claudication in peripheral vascular disease. [2] If no improvement is seen after 3 months, stopping the medication is reasonable. [ 3 ]
For men over 64 with prostate cancer limited to the pelvis, using fewer, larger doses of radiation (hypofractionation) results in similar overall survival rates. [28] The risk of dying from prostate cancer or having acute bladder side effects may be similar to that of longer radiation treatment. [28]
Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...
About 3,800 men in Scotland are diagnosed with prostate cancer annually. ... But this data gives us hope that we could have some more readily-available treatments for prostate cancer in the future
The programme consisted of three large randomized, double-blind, placebo-controlled trials in which a total of 8,113 men with localized or locally advanced prostate cancer were treated with 150 mg/day bicalutamide plus standard care (watchful waiting, radical prostatectomy, or radiation therapy) (n=4052) or given placebo (standard care alone ...
Prostate tumors were first described in the mid-19th century, during surgeries on men with urinary obstructions. Initially, prostatectomy was the primary treatment for prostate cancer. By the mid-20th century, radiation treatments and hormone therapies were developed to improve prostate cancer treatment.
Data shows that men who have a brother or father with prostate cancer are 2.5 times more likely to develop the disease and the risk increases even further if they were under 60 when diagnosed.
Ensure women are aware of their cancer profile early. "All women should know their cancer risk profile by the age of 30," Litvack says. "We all need to be in control of our own health, having the ...
Ad
related to: cilostazol treatment for prostate cancer in men